Debiopharm further describes AbYlink as a one-step method that results in stable conjugation at defined and invariable sites on the Fc domain of an antibody, with no impact on antigen-binding regions, ...

Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of ...

AusBiotech proudly welcomed a significant number of new members.Our latest members span biotechnology, medical ...

The targeted radiopharmaceutical field is undergoing significant expansion, with progressing clinical candidates and growing novel pipelines. Precision radiopharmaceuticals represent a golden ...

At close: April 29 at 1:22:10 PM CST ...